Review: taking Bactrim ds and Allopurinol together


Summary

Drug interactions are reported among people who take Bactrim ds and Allopurinol together. This review analyzes the effectiveness and drug interactions between Bactrim ds and Allopurinol. It is created by eHealthMe based on reports of 2,820 people who take the same drugs from FDA and social media, and is updated regularly.

You are not alone

Join a support group for people who take Bactrim ds and Allopurinol >>>

Personalized health information

On eHealthMe you can find out what patients like me (same gender, age) reported their drugs and conditions on FDA and social media since 1977. Our tools are free and anonymous. 86 million people have used us. 300+ peer-reviewed medical journals have referenced our original studies. Start now >>>


Bactrim Ds

Bactrim ds has active ingredients of sulfamethoxazole; trimethoprim. It is often used in urinary tract infection. (latest outcomes from Bactrim ds 7,338 users)

Allopurinol

Allopurinol has active ingredients of allopurinol. It is often used in gout. (latest outcomes from Allopurinol 56,919 users)

On Aug, 21, 2016

2,820 people who take Bactrim Ds, Allopurinol are studied.


Number of reports submitted per year:

Bactrim ds and Allopurinol drug interactions.

Drug effectiveness over time:

Bactrim Ds:
  • < 1 month: 0.0% - (0 of 1 people)
  • 1 - 6 months: 0.0% - (0 of 0 people)
  • 6 - 12 months: 0.0% - (0 of 0 people)
  • 1 - 2 years: 0.0% - (0 of 0 people)
  • 2 - 5 years: 0.0% - (0 of 0 people)
  • 5 - 10 years: 0.0% - (0 of 1 people)
  • 10+ years: 100.0% - (1 of 1 people)
  • not specified: 0.0% - (0 of 0 people)
Allopurinol:
  • < 1 month: 0.0% - (0 of 0 people)
  • 1 - 6 months: 50.0% - (1 of 2 people)
  • 6 - 12 months: 0.0% - (0 of 0 people)
  • 1 - 2 years: 0.0% - (0 of 0 people)
  • 2 - 5 years: 0.0% - (0 of 0 people)
  • 5 - 10 years: 100.0% - (1 of 1 people)
  • 10+ years: 100.0% - (2 of 2 people)
  • not specified: 0.0% - (0 of 0 people)

Drug effectiveness by gender:

Bactrim Ds:
  • female: 0.0% - (0 of 1 people)
  • male: 50.0% - (1 of 2 people)
Allopurinol:
  • female: 0.0% - (0 of 1 people)
  • male: 100.0% - (4 of 4 people)

Drug effectiveness by age:

Bactrim Ds:
  • 0-1: 0.0% - (0 of 0 people)
  • 2-9: 0.0% - (0 of 0 people)
  • 10-19: 0.0% - (0 of 0 people)
  • 20-29: 0.0% - (0 of 0 people)
  • 30-39: 0.0% - (0 of 0 people)
  • 40-49: 0.0% - (0 of 0 people)
  • 50-59: 0.0% - (0 of 1 people)
  • 60+: 50.0% - (1 of 2 people)
Allopurinol:
  • 0-1: 0.0% - (0 of 0 people)
  • 2-9: 0.0% - (0 of 0 people)
  • 10-19: 0.0% - (0 of 0 people)
  • 20-29: 0.0% - (0 of 0 people)
  • 30-39: 0.0% - (0 of 0 people)
  • 40-49: 0.0% - (0 of 0 people)
  • 50-59: 50.0% - (1 of 2 people)
  • 60+: 100.0% - (3 of 3 people)

Most common drug interactions over time *:

< 1 month:
  • pyrexia
  • renal failure acute
  • hypotension
  • febrile neutropenia
  • sepsis
  • anaemia
  • multi-organ failure
  • death
  • pneumonia
  • disseminated intravascular coagulation
1 - 6 months:
  • pyrexia
  • anaemia
  • febrile neutropenia
  • white blood cell count decreased
  • renal failure acute
  • pneumonia
  • pancytopenia
  • platelet count decreased
  • hyperglycaemia
  • hypotension
6 - 12 months:
  • blood creatinine increased
  • diarrhoea
  • platelet count decreased
  • pneumonia
  • pyrexia
  • urinary tract infection
  • transplant failure
  • acute myocardial infarction
  • chest pain
  • endocarditis
1 - 2 years:
  • hyperlipidaemia
  • hyperuricaemia
  • anaemia
  • blood alkaline phosphatase increased
  • gamma-glutamyltransferase increased
  • hepatic steatosis
  • lymphoma
  • platelet count decreased
  • disseminated intravascular coagulation
  • cerebral haemorrhage
2 - 5 years:
  • atrial fibrillation
  • decreased appetite
  • gamma-glutamyltransferase increased
  • hepatic steatosis
  • hyperlipidaemia
  • lymphoma
  • malaise
  • oedema peripheral
  • hepatic failure
  • multiple myeloma
5 - 10 years:
  • diarrhoea
  • alanine aminotransferase increased
  • aspartate aminotransferase increased
  • blood bilirubin increased
  • blood creatine phosphokinase increased
  • leukopenia
  • oliguria
  • renal failure acute
10+ years:
  • diarrhoea
not specified:
  • pyrexia
  • platelet count decreased
  • anaemia
  • thrombocytopenia
  • pneumonia
  • dyspnoea
  • fatigue
  • febrile neutropenia
  • diarrhoea
  • nausea

Most common drug interactions by gender *:

female:
  • pyrexia
  • nausea
  • febrile neutropenia
  • renal failure acute
  • anaemia
  • platelet count decreased
  • diarrhoea
  • pain
  • thrombocytopenia
  • neutropenia
male:
  • pyrexia
  • platelet count decreased
  • anaemia
  • dyspnoea
  • pneumonia
  • thrombocytopenia
  • white blood cell count decreased
  • fatigue
  • febrile neutropenia
  • renal failure acute

Most common drug interactions by age *:

0-1:
  • chloroma
  • convulsion
  • hydrocephalus
  • hypertonia
  • pyrexia
  • respiratory arrest
  • toxic epidermal necrolysis
  • acute myeloid leukaemia
  • agitation neonatal
  • feeling jittery
2-9:
  • haemolytic uraemic syndrome
  • febrile neutropenia
  • toxic epidermal necrolysis
  • cough
  • neutropenia
  • pulmonary veno-occlusive disease
  • pyrexia
  • disorientation
  • enterococcal infection
  • muscle rigidity
10-19:
  • hypotension
  • pain in extremity
  • blood bilirubin increased
  • renal failure
  • pain
  • febrile neutropenia
  • pneumonitis
  • acute respiratory distress syndrome
  • multi-organ failure
  • nephrogenic systemic fibrosis
20-29:
  • pyrexia
  • platelet count decreased
  • pneumonia
  • headache
  • abdominal pain
  • mental status changes
  • pain
  • cardiac disorder
  • convulsion
  • drug abuse
30-39:
  • pyrexia
  • haemoglobin decreased
  • platelet count decreased
  • hyperglycaemia
  • anaemia
  • dehydration
  • ataxia
  • depression
  • fatigue
  • dizziness
40-49:
  • dyspnoea
  • anxiety
  • pain
  • fatigue
  • pneumonia
  • nausea
  • renal failure
  • injury
  • neuropathy peripheral
  • hyperlipidaemia
50-59:
  • pyrexia
  • renal failure acute
  • anaemia
  • white blood cell count decreased
  • fatigue
  • pain
  • platelet count decreased
  • neutropenia
  • pancytopenia
  • febrile neutropenia
60+:
  • platelet count decreased
  • pyrexia
  • anaemia
  • thrombocytopenia
  • febrile neutropenia
  • pneumonia
  • diarrhoea
  • haemoglobin decreased
  • white blood cell count decreased
  • dyspnoea

* Approximation only. Some reports may have incomplete information.

How to use the study: print a copy of the study and bring it to your health teams to ensure drug risks and benefits are fully discussed and understood.

Do you take Bactrim ds and Allopurinol?

Can you answer these questions?

More questions for: Bactrim ds, Allopurinol

You may be interested in these reviews

More reviews for: Bactrim ds, Allopurinol

On eHealthMe, Bactrim ds (sulfamethoxazole; trimethoprim) is often used to treat urinary tract infection. Allopurinol (allopurinol) is often used to treat gout. Find out below the conditions the drugs are used for and how effective they are.

What is the drug used for and how effecitve is it:


NOTE: The study is based on active ingredients and brand name. Other drugs that have the same active ingredients (e.g. generic drugs) are NOT considered.

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only, and has not been supported by scientific studies or clinical trials unless otherwise stated. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

You may report adverse side effects to the FDA at http://www.fda.gov/medwatch/ or 1-800-FDA-1088 (1-800-332-1088).

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.